|
|
 |
|
Viewing report
|
|
|
|
Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report
Global Industry Analysts, Inc., July 2010, Pages: 432
This report analyzes the Global market for Anti-CD20 Monoclonal Antibodies in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 38 companies including many key and niche players such as Bayer Schering Pharma AG, Biocon, Biogen Idec, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genentech, Inc., Genmab A/S, GlaxoSmithKline Plc, GTC Biotherapeutics, Inc., Immunomedics, Inc., InNexus Biotechnology, Inc., LFB Group, Nycomed, Pfizer, Inc., Spectrum Pharmaceuticals, Inc., Trubion Pharmaceuticals, Inc., and UCB Pharmaceutical. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Competitor Analysis: CD20 Antibodies
Monoclonal Antibodies 2007: Competitive Landscape & Pipeline Insight
Opportunities for Monoclonal Antibodies: Where Companies Are Spending Their Antibody Dollars
Competitor Analysis - Cancer Antibodies in Early Clinical Development
Biologics Pipelines: Who Has the Next Promising Monoclonal Antibodies?
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Lymphoma Therapeutics - Global Strategic Business Report
The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging Technologies and New Therapeutic Candidates
Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects
|
|
|
|
